Share this article
Share this article
ResearchAndMarkets.com s offering.
Global Neurostimulation Devices Market to Reach $18,033.0 Million by 2030
Neurostimulation devices consider the implantable and non-implantable neurostimulation devices which act on the spinal cord and brain to deliver the electrical stimulation to a targeted area. These types of devices are mainly used in the treatment and management of Parkinson s disease, bowel and bladder dysfunction, Alzheimer s disease, and relieving chronic pain of the body.
For carrying out innovative research in the field of neurostimulation devices, companies in the market received funding and investments by a few government organizations. The global neurostimulation devices market witnessed approximately 22 funding and investments in the past four years (January 2016-May 2020). For instance, NeuroPace, Inc. received $74 million funding from KCK Group and OrbiMed Advisors for ramping the production of NeuroPace RNS System, which
Strategic Healthcare Investment Partners Closes $128M Debut Medical Devices and Digital Health Venture Fund and Rebrands Itself as Treo Ventures
News provided by
Share this article
Share this article
SANTA CLARA, Calif. and DUBLIN, Jan. 12, 2021 /PRNewswire/ Treo Ventures (formerly known as Strategic Healthcare Investment Partners-S.H.I.P.), a venture capital fund focused on investments in high impact companies at the intersection of biology and technology in medical devices and digital health, announced the successful closing of its $128 million debut fund. The fund has a presence in Silicon Valley, CA and Dublin, Ireland, and will be supporting world class entrepreneurs across these geographies. Treo has been actively investing and building a portfolio of category defining companies including Hyalex Orthopedics, CVRx, ShiraTronics, Intuity Medical, NeoChord, and Noctrix Health.
Inspire Medical Systems, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021.
Inspire is scheduled to present at 3:40 p.m. Eastern Time. The presentation will be accessible via a live webcast at:
https://jpmorgan.metameetings.net/events/healthcare21/sessions/35364-inspire-medical-systems-inc/webcast?gpu only=true&kiosk=true
Is LAZ A Good Stock To Buy Now? yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.